menu
    • menu

    Company profile for BioVie

    NEW Drugs in Dev: 4
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioVie Inc. (ticker symbol: BIVI) is a clinical-stage company developing innovative drug therapies for liver disease. Our new drug candidate, BIV201 (continuous infusion terlipressin), is currently being tested in a mid-stage (Phase 2a) clinical trial for ascites due to advanced liver cirrhosis. It has an Orphan Drug designation for the treatment of ascites, FDA Fast Track status, and US patent protection. BIV201 also has an O...
    BioVie Inc. (ticker symbol: BIVI) is a clinical-stage company developing innovative drug therapies for liver disease. Our new drug candidate, BIV201 (continuous infusion terlipressin), is currently being tested in a mid-stage (Phase 2a) clinical trial for ascites due to advanced liver cirrhosis. It has an Orphan Drug designation for the treatment of ascites, FDA Fast Track status, and US patent protection. BIV201 also has an Orphan Drug designation for the treatment of hepatorenal syndrome (HRS).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioVieUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2120 Colorado Ave., #230 Santa Monica, CA 90404
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biovieinc.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/biovie-inc.
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/biovie_inc?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioVie Completes Phase 2 SUNRISE-PD Trial in Early Parkinson
    BioVie Completes Phase 2 SUNRISE-PD Trial in Early Parkinson

    18 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/18/3296537/0/en/biovie-announces-completion-of-phase-2-sunrise-pd-trial-in-early-stage-parkinson-s-disease.html

    GLOBENEWSWIRE
    18 May 2026
    Share Share
    BioVie Hosts Virtual KOL Event On Bezisterim Phase 2 Study
    BioVie Hosts Virtual KOL Event On Bezisterim Phase 2 Study

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281541/0/en/biovie-to-host-virtual-kol-event-to-discuss-the-phase-2-study-of-bezisterim-for-the-treatment-of-parkinson-s-disease-ahead-of-topline-data-in-2q26-on-may-7-2026.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Biovie To Present Abstract At 2026 Aan Annual Meeting
    Biovie To Present Abstract At 2026 Aan Annual Meeting

    14 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/14/3273252/0/en/BioVie-Announces-Abstract-Accepted-for-Presentation-at-the-2026-American-Academy-of-Neurology-Annual-Meeting.html

    GLOBENEWSWIRE
    14 Apr 2026
    Share Share
    Biovie Plans $20M IPO For Spinout Developing Liver Disease Drug
    Biovie Plans $20M IPO For Spinout Developing Liver Disease Drug

    17 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/biovie-plans-20m-ipo-spinout-tasked-developing-liver-disease-drug

    FIERCE BIOTECH
    17 Mar 2026
    Share Share
    Biovie Announces Abstract Accepted For Presentation At AD/PD 2026
    Biovie Announces Abstract Accepted For Presentation At AD/PD 2026

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254576/0/en/BioVie-Announces-Abstract-Accepted-for-Presentation-at-AD-PD-2026.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    BioVie Abstracts Accepted at 2026 ACP Meeting
    BioVie Abstracts Accepted at 2026 ACP Meeting

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237164/0/en/BioVie-Announces-Abstracts-Accepted-for-Presentation-at-the-2026-American-College-of-Psychiatrists-Annual-Meeting.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search